We are live on ! Find out more
CDIO icon

Cardio Diagnostics

15 hedge funds and large institutions have $374K invested in Cardio Diagnostics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.05% less ownership

Funds ownership: 0.27%0.22% (-0.05%)

6% less funds holding

Funds holding: 1615 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

62% less capital invested

Capital invested by funds: $996K → $374K (-$622K)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

CDIO Hedge Fund Activity: Q3 2024 in Review

15 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q3 2024, worth a combined $374K — down 62% from $996K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CDIO and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was HRT Financial, opening a new position worth an estimated $4.5K. The largest seller was UBS Group, exiting entirely with an estimated $50K sold.

  • 15 institutional investors held Cardio Diagnostics (CDIO) as of Q3 2024, down from 16 in Q2 2024.
  • Funds reported $374K of Cardio Diagnostics stock for Q3 2024, down 62% quarter-over-quarter.
  • 2 funds opened new Cardio Diagnostics positions in Q3 2024 and 3 closed out, a net change of -1 holder.
  • The largest Cardio Diagnostics buyer in Q3 2024 was HRT Financial, an estimated $4.5K added.
  • The largest Cardio Diagnostics seller in Q3 2024 was UBS Group, an estimated $50K sold.

Based on aggregated 13F filings for Q3 2024.